title: Reducing postburn injury anemia in a Jehovah's Witness patient.
abstract: Anemia is a complication of severe burn injury. Burn patients who refuse blood transfusions, such as Jehovah's Witnesses, present difficult challenges, and treatment paradigms need to be altered to reduce blood loss and increase red cell restoration. In this report the authors present a case of a 36-year-old Jehovah's Witness who suffered a 35% TBSA burn injury. In addition to standard burn injury treatment, the authors attempted to reduce blood loss with a combination of intraoperative (tranexamic acid) and perioperative (erythropoietin, intravenous iron) strategies.
authors.affiliation: From the Division of Burn Surgery, Department of Surgery, University of California, Davis.
authors.forename: Alura
authors.initials: A
authors.lastname: Barsun
authors.forename: Soman
authors.initials: S
authors.lastname: Sen
authors.forename: Tina L
authors.initials: TL
authors.lastname: Palmieri
authors.forename: David G
authors.initials: DG
authors.lastname: Greenhalgh
mesh_terms: D000328:Adult; D000740:Anemia / Q000209:etiology / Q000517:prevention & control*; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D016063:Blood Loss, Surgical / Q000517:prevention & control; D002056:Burns / Q000150:complications* / Q000601:surgery; D004921:Erythropoietin / Q000627:therapeutic use; D005296:Ferrous Compounds / Q000627:therapeutic use; D006397:Hematinics / Q000627:therapeutic use; D006801:Humans; D033221:Jehovah's Witnesses; D008297:Male; D014148:Tranexamic Acid / Q000627:therapeutic use
chemical_list: D000933:Antifibrinolytic Agents; D005296:Ferrous Compounds; D006397:Hematinics; D004921:Erythropoietin; D014148:Tranexamic Acid; C011819:ferrous gluconate